SCHEMBL16521506

SCHEMBL16521506

Cc1ccc(-c2cc(=O)c3c(O)c(O)c(C)cc3o2)cc1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA3 P0DMS8 3/20 0.69
▸ AR P10275 2/20 0.63
▸ KMT2A Q03164 5/20 0.61
▸ GABRP O00591 4/20 0.61
▸ GABRD O14764 4/20 0.61
▸ GABRA1 P14867 4/20 0.61
▸ GABRB1 P18505 4/20 0.61
▸ GABRG2 P18507 4/20 0.61
▸ GABRB3 P28472 4/20 0.61
▸ GABRA5 P31644 4/20 0.61
▸ GABRA3 P34903 4/20 0.61
▸ GABRA2 P47869 4/20 0.61
▸ GABRB2 P47870 4/20 0.61
▸ GABRA4 P48169 4/20 0.61
▸ GABRE P78334 4/20 0.61
▸ GABRA6 Q16445 4/20 0.61
▸ GABRG1 Q8N1C3 4/20 0.61
▸ GABRG3 Q99928 4/20 0.61
▸ GABRQ Q9UN88 4/20 0.61
▸ CYP1A1 P04798 3/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13287220 0.88 ABCB1 (0.74) ARKMT2AGABRPGABRDGABRA1
SCHEMBL16521507 0.86 MAPT (0.71) ADORA3KMT2AGABRPGABRDGABRA1
SCHEMBL16521508 0.86 ABCB1 (0.55) ADORA3KMT2AGABRPGABRDGABRA1
SCHEMBL16521509 0.85 AR (0.63) ADORA3ARKMT2AGABRPGABRD
SCHEMBL20664384 0.82 FLT3 (0.53) ADORA3KMT2AGABRPGABRDGABRA1
SCHEMBL31060888 0.82 ADORA3 (1.00) ADORA3ARKMT2AGABRPGABRD
SCHEMBL25858984 0.81 CBS (0.73) ADORA3ARKMT2AGABRPGABRD
SCHEMBL12636897 0.79 CYP1B1 (0.81) ARKMT2AGABRPGABRDGABRA1
SCHEMBL17265620 0.78 ABCB1 (0.80) ADORA3ARKMT2AGABRPGABRD
SCHEMBL12636899 0.78 AR (1.00) ARKMT2ACYP1A1CYP1B1FTO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150056166-A1 FLAVONE DERIVATIVES AND THEIR USE TWINCORE GMBH (DE) 2015-02-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150056166-A1 FLAVONE DERIVATIVES AND THEIR USE MAVS, ZC3HAV1, EBNA1BP2 ADORA3 4596/4885AR 4221/4885KMT2A 1816/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback